FATE NASDAQ
Fate Therapeutics, Inc.
1W: -1.3%
1M: -5.3%
3M: -22.4%
YTD: +107.1%
1Y: +109.0%
3Y: -12.8%
5Y: -97.3%
$2.32
+0.02 (+0.87%)
Weekly Expected Move ±5.8%
$2
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-06-30
Earliest Filing
2023-11-08
Latest Filing
partner: 3
Counterparties (Filed by FATE)
3 relationshipsCompanies named in FATE's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Jefferies LLC | JEF | partner | Sales agent for at-the-market offering program | 2023-11-08 | View |
| Ono Pharmaceutical Co., Ltd. | — | partner | Partnered with Fate Therapeutics for joint development and commercialization of HER2-targeted CAR T-cell product candida | 2022-11-07 | View |
| Ono Pharmaceutical Co. Ltd. | — | partner | Expanded collaboration agreement for iPSC-derived CAR NK and CAR T-cell cancer immunotherapy development. | 2022-06-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-28 | Other Events; Exhibits | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-15 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-04 | Other Events; Exhibits | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-27 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-14 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Fi | View | |
| 2025-06-17 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-30 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-11-29 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-30 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2024-06-10 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2024-06-07 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR